EARNINGS/SALES RELEASESColoplast has reported a 8% rise in Q2 23 revenue, driven by double-digit growth in wound and skin care, and in interventional urology. However, gross margin erosion and higher. | May 11, 2023
As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.The programme commenced on 21 February 2022 and will end no later than. | April 25, 2022
23 August 2021.
The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the
European Parliament and Council of
16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.
The following transactions have been executed during the period 6 –
9 April 2021: